Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 33 | 33 | 33 |
| Accounts receivable | -85 | 12 | -35 | 7 | 55 |
| Other Working Capital | 143 | 103 | 156 | 109 | 210 |
| Other Operating Activity | -79 | -162 | -123 | -228 | -647 |
| Operating Cash Flow | $-21 | $-47 | $32 | $-79 | $-349 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 0 | 102 | 372 |
| Debt Repayment | 0 | 43 | -43 | -42 | -42 |
| Financing Cash Flow | $0 | $43 | $-43 | $59 | $330 |
| Beginning Cash Position | 35 | 39 | 50 | 25 | 44 |
| End Cash Position | 14 | 35 | 39 | 50 | 25 |
| Net Cash Flow | $-21 | $-4 | $-11 | $25 | $-19 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21 | -47 | 32 | -79 | -349 |
| Free Cash Flow | -21 | -47 | 32 | -79 | -349 |